Predictive validity of SOFA-2: analytical and contextual considerations

Category	Detail
Condition	Sequential Organ Failure Assessment (SOFA-2)
Key Mechanisms	Predictive validity against 30-day mortality in ICU admissions
Target Population	ICU patients, including trauma and sepsis populations
Care Setting	Intensive Care Unit (ICU)

SOFA-2 shows a small discriminative advantage over SOFA-1 on ICU day 1.
Reclassification rates between SOFA-1 and SOFA-2 are high but yield minimal net improvement.
Predictive validity of SOFA-2 varies significantly by case-mix, particularly between trauma and sepsis patients.
Temporal decay of SOFA predictive validity limits its use as a longitudinal prognostic tool.
SOFA-2 components were not manually validated, raising concerns about prognostic imbalance.

SOFA-2 should be used with caution, particularly in high-severity and sepsis subgroups.

Serial SOFA measurements may not accurately reflect mortality risk due to competing risks.

Unvalidated components of SOFA-2 may lead to systematic errors in patient reclassification.

ICU patients with varying degrees of organ dysfunction

SOFA-2's predictive validity is influenced by patient age and comorbidities.

Use SOFA-2 primarily as an admission snapshot rather than a longitudinal tracker.
Future studies should focus on manual validation of SOFA-2 components.